The Dr Doug Show | Bones, Hormones and HealthSpan

Zoledronate (Reclast) for 10 Years: Fracture Prevention at What Cost to Bone Turnover?

Feb 9, 2026 · 0:13:59

Listen to Episode

✨ AI Summary

Long-term zoledronate use reduced vertebral fractures.
Bone density plateaued, and bone turnover remained suppressed.
Questions arise about long-term fracture prevention costs to bone turnover.

More from The Dr Doug Show | Bones, Hormones and HealthSpan

The Worst Osteoporosis Drug in 2026? This Might Surprise You

Mar 30, 2026 · 0:11:48

Osteoporosis Supplements Explained: Calcium, Vitamin K2, and Strontium | Dr. John Neustadt

Mar 25, 2026 · 0:58:57

Estradiol, Testosterone, and Bone Density: What the Data Really Shows

Mar 16, 2026 · 0:21:22

New OsteoStrong Study: Does Osteogenic Loading Improve Bone Density?

Mar 9, 2026 · 0:17:11

View all episodes →